AIMS: One tool for protecting quality use of medicines in hospitals is a drug and therapeutics committee (DTC) that oversees medicines availability. Pharmaceutical industry marketing to prescribers is associated with less appropriate prescribing and increased costs. There is little data on decision-making practices of DTCs so it is unknown whether or how they might be vulnerable to pharmaceutical industry influence. This project explores DTC decision-making with a focus on how pharmaceutical industry influence on access and use of medicines is identified and managed. METHODS: We used a qualitative methodology with individual interviews of 29 participants who were current or recent members of public hospital DTCs across New South Wales, Aust...
The guidelines proposed by Brennan et al to mitigate the influence of pharmaceutical company marketi...
The pharmaceutical industry has been criticised for pervasive misconduct. These concerns have genera...
The Pharmaceutical Management Agency of New Zealand (PHARMAC) and the Pharmaceutical Benefits Scheme...
Aims: One tool for protecting quality use of medicines in hospitals is a drug and therapeutics commi...
Background: Pharmaceutical industry involvement in biomedicine has produced major benefits but has a...
One of the many responsibilities of the profession of pharmacy is to serve as a gatekeeper for phar...
PHARMAC, the Pharmaceutical Management Agency, manages the Pharmaceutical Schedule on behalf of the ...
Aim: To investigate the perceptions, concerns and attitudes of decision-makers regarding access to h...
Objectives: To analyse patterns and characteristics of pharmaceutical industry sponsorship of events...
Transparency has become one of the primary themes in health care reform efforts in the United States...
Aim To investigate the perceptions, concerns and attitudes of decision-makers regarding access to hi...
Background: Access to 'high-cost medicines' under Australia's Pharmaceutical Benefits Scheme (PBS) i...
Aims To determine structure, activities and drug selection processes used by Dutch hospital drug and...
Growing pharmaceutical demands in communities and institutions challenge healthcare organizations to...
The International Pharmaceutical Federation (FIP) Basel Statements on the future of hospital pharmac...
The guidelines proposed by Brennan et al to mitigate the influence of pharmaceutical company marketi...
The pharmaceutical industry has been criticised for pervasive misconduct. These concerns have genera...
The Pharmaceutical Management Agency of New Zealand (PHARMAC) and the Pharmaceutical Benefits Scheme...
Aims: One tool for protecting quality use of medicines in hospitals is a drug and therapeutics commi...
Background: Pharmaceutical industry involvement in biomedicine has produced major benefits but has a...
One of the many responsibilities of the profession of pharmacy is to serve as a gatekeeper for phar...
PHARMAC, the Pharmaceutical Management Agency, manages the Pharmaceutical Schedule on behalf of the ...
Aim: To investigate the perceptions, concerns and attitudes of decision-makers regarding access to h...
Objectives: To analyse patterns and characteristics of pharmaceutical industry sponsorship of events...
Transparency has become one of the primary themes in health care reform efforts in the United States...
Aim To investigate the perceptions, concerns and attitudes of decision-makers regarding access to hi...
Background: Access to 'high-cost medicines' under Australia's Pharmaceutical Benefits Scheme (PBS) i...
Aims To determine structure, activities and drug selection processes used by Dutch hospital drug and...
Growing pharmaceutical demands in communities and institutions challenge healthcare organizations to...
The International Pharmaceutical Federation (FIP) Basel Statements on the future of hospital pharmac...
The guidelines proposed by Brennan et al to mitigate the influence of pharmaceutical company marketi...
The pharmaceutical industry has been criticised for pervasive misconduct. These concerns have genera...
The Pharmaceutical Management Agency of New Zealand (PHARMAC) and the Pharmaceutical Benefits Scheme...